BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32631022)

  • 1. A Rare Cause of Type II Neovascularization: Unilateral Retinal Pigment Epithelium Dysgenesis.
    Şekeryapan Gediz B
    Turk J Ophthalmol; 2020 Jun; 50(3):187-189. PubMed ID: 32631022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
    Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FINDINGS IN A CASE OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO UNILATERAL RETINAL PIGMENT EPITHELIUM DYSGENESIS TREATED WITH INTRAVITREAL BEVACIZUMAB THERAPY.
    Preziosa C; Staurenghi G; Pellegrini M
    Retin Cases Brief Rep; 2021 Sep; 15(5):598-601. PubMed ID: 30688847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DIFFERENCE IN TREATMENT OUTCOMES ACCORDING TO OPTICAL COHERENCE TOMOGRAPHY-BASED STAGES IN TYPE 3 NEOVASCULARIZATION (RETINAL ANGIOMATOUS PROLIFERATION).
    Kim JH; Chang YS; Kim JW; Kim CG; Lee DW; Cho SY
    Retina; 2018 Dec; 38(12):2356-2362. PubMed ID: 29019795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic Correlation of Anti-Vascular Endothelial Growth Factor-Treated Type 3 Neovascularization in Age-Related Macular Degeneration.
    Li M; Dolz-Marco R; Messinger JD; Wang L; Feist RM; Girkin CA; Gattoussi S; Ferrara D; Curcio CA; Freund KB
    Ophthalmology; 2018 Feb; 125(2):276-287. PubMed ID: 28964579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal retinal pigment epithelium atrophy at the location of type 3 neovascularization lesion: a morphologic feature associated with low reactivation rate and favorable prognosis.
    Kim JH; Kim JW; Kim CG; Lee DW
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1661-1669. PubMed ID: 31144056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of anatomical and visual outcomes following different anti-vascular endothelial growth factor treatments in subretinal neovascular membrane secondary to type 2 proliferative macular telangiectasia.
    Karasu B; Gunay BO
    Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):99-106. PubMed ID: 31768680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROGRESSION OF MACULAR ATROPHY IN EYES WITH TYPE 1 NEOVASCULARIZATION AND AGE-RELATED MACULAR DEGENERATION RECEIVING LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: An Optical Coherence Tomographic Angiography Analysis.
    Christenbury JG; Phasukkijwatana N; Gilani F; Freund KB; Sadda S; Sarraf D
    Retina; 2018 Jul; 38(7):1276-1288. PubMed ID: 28723848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography.
    Clemens CR; Alten F; Termühlen J; Mihailovic N; Rosenberger F; Heiduschka P; Eter N
    Graefes Arch Clin Exp Ophthalmol; 2020 Jul; 258(7):1411-1417. PubMed ID: 32306096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHANGES IN EARLY TYPE 3 NEOVASCULARIZATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT.
    Miere A; Querques G; Semoun O; Amoroso F; Zambrowski O; Chapron T; Capuano V; Souied EH
    Retina; 2017 Oct; 37(10):1873-1879. PubMed ID: 28079756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Effects in Retinal Angiomatous Proliferation Imaged with OCT Angiography.
    de Jong JH; Braaf B; Amarakoon S; Gräfe M; Yzer S; Vermeer KA; Missotten T; de Boer JF; van Velthoven MEJ
    Ophthalmologica; 2019; 241(3):143-153. PubMed ID: 30227415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.
    Lotfy A; Solaiman KAM; Abdelrahman A; Samir A
    Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up for type 1 (subretinal pigment epithelium) neovascularization using a modified "treat and extend" dosing regimen of intravitreal antivascular endothelial growth factor therapy.
    Engelbert M; Zweifel SA; Freund KB
    Retina; 2010 Oct; 30(9):1368-75. PubMed ID: 20517175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of indocyanine green angiography in a case of unilateral retinal pigment epithelium dysgenesis.
    Cervera-Taulet E; Montero-Hernández J; Monferrer Adsuara C; Pulido JS
    Eur J Ophthalmol; 2024 May; 34(3):NP46-NP52. PubMed ID: 37649336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical coherence tomography angiography in treated type 2 neovascularization undergoing monthly anti-VEGF treatment.
    Parravano M; Querques L; Scarinci F; Giorno P; De Geronimo D; Gattegna R; Varano M; Bandello F; Querques G
    Acta Ophthalmol; 2017 Aug; 95(5):e425-e426. PubMed ID: 27496070
    [No Abstract]   [Full Text] [Related]  

  • 16. TIME COURSE OF CHANGES IN OPTIC DISK NEOVASCULARIZATION AFTER A SINGLE INTRAVITREAL BEVACIZUMAB INJECTION.
    Falavarjani KG; Habibi A; Khorasani MA; Anvari P; Sadda SR
    Retina; 2019 Jun; 39(6):1149-1153. PubMed ID: 29466258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical coherence tomography-angiography for monitoring neovascularisations in macular telangiectasia type 2.
    Tzaridis S; Hess K; Friedlander M; Holz FG
    Br J Ophthalmol; 2021 May; 105(5):735-740. PubMed ID: 32513667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital Hypertrophy of the Retinal Pigment Epithelium Presenting With Secondary Choroidal Neovascularization.
    Garoon RB; Harbour JW
    Ophthalmic Surg Lasers Imaging Retina; 2018 Apr; 49(4):276-277. PubMed ID: 29664987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion.
    Januschowski K; Feltgen N; Pielen A; Spitzer B; Rehak M; Spital G; Dimopoulos S; ; Meyer CH; Szurman GB
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):457-462. PubMed ID: 27632214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal pigment epithelium hyperplasia overlying pigment epithelial detachment in age-related macular degeneration can masquerade as neovascularization on optical coherence tomography angiography.
    Chen L; Zhang X; Gan Y; Liu B; Zhang Y; Wen F
    Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2283-2291. PubMed ID: 30229304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.